Literature DB >> 17313610

Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.

P I Karakiewicz1, S Benayoun, L R Bégin, A Duclos, L Valiquette, M McCormack, F Bénard, F Saad, P Perrotte.   

Abstract

Tissue inflammation has been linked to cancer in several disease models. We tested the association between chronic inflammation and prostate cancer (PCa), as well as high-grade prostatic intraepithelial neoplasia (HGPIN), in prostatic needle biopsy specimens. Tissues from 4526 men, who underwent systematic ultrasound-guided sextant needle biopsies of the prostate, were classified in the following order as PCa, or HGPIN, or chronic inflammation or benign. PCa was diagnosed in 1633 (36.1%), HGPIN in 535 (11.8%) and chronic inflammation in 347 (7.7%). Chronic inflammation conferred a protective effect from PCa: odds ratio (OR) = 0.20, 95% confidence interval (CI) = 0.15-0.28. Chronic inflammation was also inversely associated with HGPIN: OR = 0.11, 95% CI = 0.05-0.22. The ORs remained virtually unchanged after adjustment for age, serum prostate-specific antigen (PSA), digital rectal examination (DRE) and gland volume. Chronic inflammation is more frequent in the presence of benign histology than it is in the presence of PCa or HGPIN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313610     DOI: 10.1111/j.1742-1241.2006.00905.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  20 in total

1.  Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Authors:  B A Rybicki; O N Kryvenko; Y Wang; M Jankowski; S Trudeau; D A Chitale; N S Gupta; A Rundle; D Tang
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-01       Impact factor: 5.554

2.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

3.  Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.

Authors:  Emma H Allott; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-09

4.  Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.

Authors:  Emma H Allott; Sarah C Markt; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Lorelei A Mucci; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-04-18       Impact factor: 4.254

5.  Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.

Authors:  Mya Sanda Thein; Anita Kohli; Rohit Ram; Maria Clara Ingaramo; Alka Jain; Neal S Fedarko
Journal:  Cancer Biomark       Date:  2017-07-04       Impact factor: 4.388

6.  The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis.

Authors:  Sudha M Sadasivan; Yalei Chen; Nilesh S Gupta; Xiaoxia Han; Kevin R Bobbitt; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang Tang; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

7.  A novel method to identify and isolate proliferative inflammatory atrophy (PIA) clusters and to extract high-quality PIA RNA.

Authors:  Yibing Wang; Chao Hao; Bin Fu; Weipeng Liu; Xiaocheng Zhou; Tao Zeng; Ju Guo; Gongxian Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

8.  Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.

Authors:  Alicia C McDonald; Manish A Vira; Adriana C Vidal; Wenqi Gan; Stephen J Freedland; Emanuela Taioli
Journal:  Prostate       Date:  2014-01-16       Impact factor: 4.104

9.  Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.

Authors:  Markku H Vaarala; Aare Mehik; Pasi Ohtonen; Pekka A Hellström
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

10.  Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.

Authors:  D M Berney; F Algaba; P Camparo; E Compérat; D Griffiths; G Kristiansen; A Lopez-Beltran; R Montironi; M Varma; L Egevad
Journal:  Virchows Arch       Date:  2014-03-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.